Apple (AAPL) rallies after fiscal Q3 earnings beat >>> READ MORE

Pharma Stock May Be Just What the Doctor Ordered

The Medicines Company is trading in very bullish pattern supported by a stochastic buy

   

The Medicines Company (NASDAQ:MDCO) — This pharmaceutical company is focused on the treatment of critical care patients through the global hospital network. All of its acute-care, generic products are injectable. It recently entered into an agreement with AstraZeneca (NYSE:AZN) to market a key heart drug called Brilinta.

Analysts estimate that the company will earn 90 cents in 2012 and $1.26-plus in 2013.

Technically the stock broke from a right triangle in June, and then retreated to its uptrend line and 50-day moving average where it found support.

In July, it gapped higher as part of a bullish flag formation and recently popped from its 50-day moving average again. This is a very bullish pattern, and it supported by a buy from the stochastic. Our trading target for MDCO is $30-plus.

Trade of the Day – The Medicines Company (NASDAQ:MDCO)
Click to Enlarge

Trade of the Day Chart Key


Article printed from InvestorPlace Media, http://investorplace.com/2012/08/trade-of-the-day-the-medicines-company-nasdaq-mdco/.

©2016 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.